These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1959448)

  • 21. Designing immunogens for the generation of antibodies that catalyse the hydrolysis of cocaine.
    Hagi-Pavli E; Gallacher G
    Biochem Soc Trans; 1997 Feb; 25(1):83S. PubMed ID: 9056981
    [No Abstract]   [Full Text] [Related]  

  • 22. Characterization of the mechanism of action of a catalytic antibody.
    Martin MT; Schantz AR; Schultz PG; Rees AR
    Ciba Found Symp; 1991; 159():188-97; discussion 197-200. PubMed ID: 1959447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the hydrolytic activity of a polyclonal catalytic antibody preparation by pH-dependence and chemical modification studies: evidence for the involvement of Tyr and Arg side chains as hydrogen-bond donors.
    Resmini M; Vigna R; Simms C; Barber NJ; Hagi-Pavli EP; Watts AB; Verma C; Gallacher G; Brocklehurst K
    Biochem J; 1997 Aug; 326 ( Pt 1)(Pt 1):279-87. PubMed ID: 9337880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cucurbit[7]uril as a Supramolecular Artificial Enzyme for Diels-Alder Reactions.
    Palma A; Artelsmair M; Wu G; Lu X; Barrow SJ; Uddin N; Rosta E; Masson E; Scherman OA
    Angew Chem Int Ed Engl; 2017 Dec; 56(49):15688-15692. PubMed ID: 29048713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent progress in asymmetric bifunctional catalysis using multimetallic systems.
    Shibasaki M; Kanai M; Matsunaga S; Kumagai N
    Acc Chem Res; 2009 Aug; 42(8):1117-27. PubMed ID: 19435320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The generation of antibody combining sites containing catalytic residues.
    Shokat KM; Schultz PG
    Ciba Found Symp; 1991; 159():118-28; discussion 128-34. PubMed ID: 1959444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A polyclonal antibody preparation with Michaelian catalytic properties.
    Gallacher G; Jackson CS; Searcey M; Badman GT; Goel R; Topham CM; Mellor GW; Brocklehurst K
    Biochem J; 1991 Nov; 279 ( Pt 3)(Pt 3):871-81. PubMed ID: 1953683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catalytic antibodies--a new window on protein chemistry.
    Suckling CJ
    Biochem Soc Trans; 1992 Feb; 20(1):216-20. PubMed ID: 1633947
    [No Abstract]   [Full Text] [Related]  

  • 29. The enzymic nature of antibody catalysis: development of multistep kinetic processing.
    Benkovic SJ; Adams JA; Borders CL; Janda KD; Lerner RA
    Science; 1990 Nov; 250(4984):1135-9. PubMed ID: 2251500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Control of the exo and endo pathways of the Diels-Alder reaction by antibody catalysis.
    Gouverneur VE; Houk KN; de Pascual-Teresa B; Beno B; Janda KD; Lerner RA
    Science; 1993 Oct; 262(5131):204-8. PubMed ID: 8211138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catalytic asymmetric hydrolysis: asymmetric hydrolytic protonation of enol esters catalyzed by phase-transfer catalysts.
    Yamamoto E; Nagai A; Hamasaki A; Tokunaga M
    Chemistry; 2011 Jun; 17(26):7178-82. PubMed ID: 21567507
    [No Abstract]   [Full Text] [Related]  

  • 32. Designed four-helix bundle catalysts--the engineering of reactive sites for hydrolysis and transesterification reactions of p-nitrophenyl esters.
    Baltzer L; Broo KS; Nilsson H; Nilsson J
    Bioorg Med Chem; 1999 Jan; 7(1):83-91. PubMed ID: 10199659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The asymmetric hetero-Diels-Alder reaction in the syntheses of biologically relevant compounds.
    Eschenbrenner-Lux V; Kumar K; Waldmann H
    Angew Chem Int Ed Engl; 2014 Oct; 53(42):11146-57. PubMed ID: 25220929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Off-the-shelf proteins that rival tailor-made antibodies as catalysts.
    Hollfelder F; Kirby AJ; Tawfik DS
    Nature; 1996 Sep; 383(6595):60-2. PubMed ID: 8779715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The state of antibody catalysis.
    Smithrud DB; Benkovic SJ
    Curr Opin Biotechnol; 1997 Aug; 8(4):459-66. PubMed ID: 9265726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highly enantioselective Diels-Alder reactions of maleimides catalyzed by activated chiral oxazaborolidines.
    Mukherjee S; Corey EJ
    Org Lett; 2010 Feb; 12(3):632-5. PubMed ID: 20063859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allosterically activated Diels-Alder catalysis by a ribozyme.
    Helm M; Petermeier M; Ge B; Fiammengo R; Jäschke A
    J Am Chem Soc; 2005 Aug; 127(30):10492-3. PubMed ID: 16045328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Catalytic activity of an encaged Verkade's superbase in a base-catalyzed Diels-Alder reaction.
    Chatelet B; Dufaud V; Dutasta JP; Martinez A
    J Org Chem; 2014 Sep; 79(18):8684-8. PubMed ID: 25132071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Graphene Oxide as a Carbocatalyst for a Diels-Alder Reaction in an Aqueous Medium.
    Girish YR; Pandit S; Pandit S; De M
    Chem Asian J; 2017 Sep; 12(18):2393-2398. PubMed ID: 28815919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence that the mechanism of antibody-catalysed hydrolysis of arylcarbamates can be determined by the structure of the immunogen used to elicit the catalytic antibody.
    Boucher G; Said B; Ostler EL; Resmini M; Brocklehurst K; Gallacher G
    Biochem J; 2007 Feb; 401(3):721-6. PubMed ID: 17020536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.